Nov 04, 2021 / 12:00PM GMT
Operator
Good morning, and welcome to the Baudax Bio Third Quarter 2021 Financial Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded at the Company's request. I would now like to turn the call over to Claudia Styslinger, Investor Relations. You may begin.
Claudia Styslinger - Argot Partners, LLC - Investor Relations Associate
Good morning, and thank you for joining us on today's conference call to discuss Baudax Bio's third quarter 2021 financial results. This is Claudia Styslinger, and I am joined today by Gerri Henwood, President and Chief Executive Officer; and Rick Casten, Chief Financial Officer. On today's call, Gerri will provide some introductory remarks, provide a business update, and discuss the continued progress around the commercialization of ANJESO. Following Gerri's prepared remarks, Rick will discuss the financial highlights from the quarter.
Earlier this morning, we issued a press release detailing our financial results for the third quarter of 2021. The press release, along with the slide
Q3 2021 Baudax Bio Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot